We are live on
!
Find out more
SFO
Standard Family Office Portfolio holdings
AUM
$96.8M
1-Year Est. Return
17.11%
This Fund
S&P 500
This Quarter
Est. Return
-5.91%
1 Year Est. Return
+17.11%
3 Year Est. Return
+57.43%
5 Year Est. Return
+58.2%
10 Year Est. Return
–
AUM
$227M
AUM Growth
+$217M
(+2,152%)
Cap. Flow
+$242M
Cap. Flow
% of AUM
106.47%
Top 10 Holdings %
Top 10 Hldgs %
90.01%
Holding
495
New
277
Increased
–
Reduced
–
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$155M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$31.5M |
| 3 |
Vanguard Extended Market ETF
VXF
|
+$22.2M |
| 4 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$10.8M |
| 5 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NPTN
NEOPHOTONICS CORP
NPTN
|
+$126K |
| 2 |
SNP
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
|
+$10K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.28% |
| 2 | Healthcare | 1.52% |
| 3 | Industrials | 1.34% |
| 4 | Financials | 1.32% |
| 5 | Consumer Discretionary | 0.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Neurocrine Biosciences
NBIX
$16.6B
| $40K | 0.02% |
377
| – | – |
|
152
WEC Energy
WEC
$35.1B
| $40K | 0.02% |
451
| – | – |
|
153
Astronics
ATRO
$3.84B
| $39K | 0.02% |
+6,000
| New | +$50.1K |
|
154
EOG Resources
EOG
$70.7B
| $39K | 0.02% |
350
| – | – |
|
155
Illinois Tool Works
ITW
$84.5B
| $39K | 0.02% |
+215
| New | +$42.4K |
|
156
Lam Research
LRCX
$390B
| $39K | 0.02% |
+1,060
| New | +$47.2K |
|
157
Pentair
PNR
$11B
| $39K | 0.02% |
950
| – | – |
|
158
Alliant Energy
LNT
$18B
| $38K | 0.02% |
+725
| New | +$43.7K |
|
159
Travelers Companies
TRV
$80.2B
| $38K | 0.02% |
+250
| New | +$40.6K |
|
160
Allstate
ALL
$67.5B
| $37K | 0.02% |
+300
| New | +$37.3K |
|
161
Ciena
CIEN
$58.4B
| $37K | 0.02% |
+927
| New | +$44.5K |
|
162
Cooper Companies
COO
$14.5B
| $37K | 0.02% |
+568
| New | +$43.5K |
|
163
Rio Tinto
RIO
$164B
| $37K | 0.02% |
+670
| New | +$38.6K |
|
164
Etsy
ETSY
$7.85B
| $36K | 0.02% |
360
| – | – |
|
165
Akamai
AKAM
$15.9B
| $35K | 0.02% |
437
| – | – |
|
166
Baxter International
BAX
$14.2B
| $35K | 0.02% |
+650
| New | +$39.1K |
|
167
Digi International
DGII
$3.1B
| $35K | 0.02% |
+1,000
| New | +$31K |
|
168
NXP Semiconductors
NXPI
$60.4B
| $35K | 0.02% |
238
| – | – |
|
169
Accenture
ACN
$108B
| $32K | 0.01% |
126
| – | – |
|
170
Kearny Financial
KRNY
$599M
| $32K | 0.01% |
3,000
| – | – |
|
171
Novartis
NVS
$297B
| $32K | 0.01% |
425
| – | – |
|
172
Azenta
AZTA
$1.48B
| $31K | 0.01% |
+717
| New | +$42.8K |
|
173
KT
KT
$8.81B
| $31K | 0.01% |
2,531
| – | – |
|
174
Shell
SHEL
$245B
| $31K | 0.01% |
+630
| New | +$32.5K |
|
175
PNC Financial Services
PNC
$101B
| $30K | 0.01% |
+200
| New | +$32.4K |
|
Similar funds
YF
WAM
SIM
ACM
CSW
JKSF
BFA
BJB
Standard Family Office's Q3 2022 Portfolio in Review
As of Q3 2022, Standard Family Office held 495 positions worth $227M, up 2,152% from $10.1M the previous quarter. Its ten largest holdings account for 90% of the portfolio.
Standard Family Office deployed $242M of net new capital in Q3 2022, opening 277 new positions. Its largest new stake was Vanguard S&P 500 ETF: 424,294 shares worth $139M.
By sector, the portfolio is most concentrated in Technology at 2.3% of assets, down from 19% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the most notable exit was NEOPHOTONICS CORP, an estimated $126K sold.
- Standard Family Office's largest Q3 2022 buy was Vanguard S&P 500 ETF: 424,294 shares worth $139M.
- Standard Family Office fully exited NEOPHOTONICS CORP in Q3 2022, selling an estimated $126K.
- Standard Family Office's ten largest holdings make up 90% of its $227M portfolio in Q3 2022.
- Standard Family Office opened 277 new positions and closed 2 in Q3 2022.
- Standard Family Office's portfolio value rose 2,152% quarter-over-quarter to $227M.
Based on Standard Family Office's 13F filing for Q3 2022, filed 10 Nov 2022.